CLINICAL_TRIALS
trial_result
· 2016-09-13
Clinical Trial Update: Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors [Phase 1]
Summary
Phase 1 study assessing the safety and feasibility of combining propranolol (Hemangiol) with oral metronomic vinorelbine (Navelbine) in children and adolescents…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Pediatric Cancer | Phase 1 | Status: UNKNOWN